SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-22-000021
Filing Date
2022-08-09
Accepted
2022-08-09 17:28:08
Documents
82
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx-20220630.htm   iXBRL 10-Q 1855208
2 EX-10.3 exhibit103acacia-formofgua.htm EX-10.3 131900
3 EX-31.1 exhibit311q22022.htm EX-31.1 8482
4 EX-31.2 exhibit312q22022.htm EX-31.2 8441
5 EX-32.1 exhibit321q22022.htm EX-32.1 9043
  Complete submission text file 0000827871-22-000021.txt   8911723

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20220630.xsd EX-101.SCH 48249
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20220630_cal.xml EX-101.CAL 93776
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20220630_def.xml EX-101.DEF 239031
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20220630_lab.xml EX-101.LAB 687590
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20220630_pre.xml EX-101.PRE 438891
76 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20220630_htm.xml XML 1673496
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 221149575
SIC: 2834 Pharmaceutical Preparations